Miss Herdman faced three charges.
The first was that she indicated to a friend that she would supply diazepam and/or tramadol for use by their husband.
The second was that she supplied diazepam and/or tramadol and/or gabapentin.
The third was that she gave advice on the dosages of diazepam and/or tramadol and/or gabapentin.
Miss Herdman was not present at the hearing and was unrepresented, but the Committee determined that it was appropriate to proceed in her absence as she had been notified, was aware that the hearing was taking place and her absence was voluntary.
However, Miss Herdman had been in contact to indicate her pleas to the charges.
She admitted the intention to supply diazepam and/or tramadol and that she had provided advice on the dosages.
She also admitted that she had supplied diazepam but strongly denied that she had supplied tramadol and/or gabapentin.
Taking all the evidence into account (including messages sent by Miss Herdman and her admissions), the Committee found proven the charges in relation to the intent to supply and the advice on dosages.
The Committee also found proven the charge in relation to the supply of diazepam, but found not proved the charge relating to the supply of tramadol and gabapentin for several reasons, including the fact that the messages sent by Miss Herdman did not point unequivocally to her actually suppling each of the drugs to which she referred.
There was no suggestion that the diazepam was stolen from her place of work.
The Committee found that Miss Herdman’s actions had breached paragraphs 1.5 and 6.5 of the Code of Professional Conduct for Veterinary Nurses.
The committee judged that there were a number of aggravating features of Miss Herdman’s conduct, including that she was not qualified or authorised to prescribe medication to animals, let alone to human beings and that providing a controlled drug to a person who was already taking various painkilling medications was reckless.
The Committee also felt that a reasonable and informed member of the public would be very concerned to learn that a veterinary nurse had supplied a controlled drug to a friend for their personal use.
Regarding the sanction for Miss Herdman, Paul Morris, chairing the Veterinary Nursing Disciplinary Committee and speaking on its behalf, said: “Drawing all the material together, and considering the matter as a whole, the Committee had to impose a proportionate sanction for an isolated incident of serious professional misconduct which arose out of a misguided attempt to help a friend.
"The conduct in question was entirely out of keeping with Miss Herdman’s usual practice and there is no real risk that it will be repeated.
"However, this case was much too serious to take no further action and no useful purpose would be served by postponing a sanction.
“The Committee considered that a warning or reprimand would not be sufficient to satisfy the public interest as veterinary nurses are trusted by the public to deal with medication responsibly and failure to do constitutes a severe breach of trust.
“The Committee therefore considered a period of suspension sufficient to meet the public interest in maintaining the reputation of the profession and declaring and upholding proper standards of conduct for members of the profession.
“The Committee also considered whether a removal order would be appropriate but concluded it would be disproportionate and that such a step would remove from the profession an experienced, competent and valuable veterinary nurse for no discernible benefit.
“It was decided that Miss Herdman’s registration be suspended for a period of three months – a period which is sufficient to mark the gravity of the misconduct while taking into account the circumstances in which it arose.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The webinars are presented by Dr Rachel Dean BVMS PhD MSc(EBHC) DSAM(fel) SFHEA MRCVS, Clinical Associate Professor in Feline Medicine at the School of Veterinary Medicine and Science, Nottingham and founding Director of the Centre for Evidence-Based Veterinary Medicine (pictured right).
The first webinar kicks off at 8:00pm on Tuesday 17th April, when Rachel will give an introduction to EBVM and reminder of why it is so important in practice.
The second session will follow on 24th April, when Rachel will explain how to find and evaluate evidence, and how you can use it to underpin your clinical decision-making process in practice.
In the final webinar, on Tuesday 1st May, Rachel will use a nutritional case study to demonstrate the real-world clinical application of EBVM concepts.
Lee Danks BVSc BVMS MRCVS, Royal Canin’s Scientific Affairs Manager said: "In this three-part series we hope to summarise EBVM for those unaccustomed to this approach and review how it can help improve our clinical decision-making in practice.
"By taking a step by step approach and delivering 'easily-digestible' lessons over three weeks we hope to answer as many questions vets and nurses have as possible with some highly applicable content from Rachel Dean."
For more information and to register, visit https://vetportal.royalcanin.co.uk/cpd/webinar2018/
What3words divides the globe into a grid of 57 trillion squares measuring three metres by three metres and gives each one a unique, 3 word name.
The app uses the GPS on your mobile phone to display your approximate position on a map, which you can then zoom in on and pinpoint more precisely. It then gives you the 3 word address for the square you're in.
The reason the emergency services recommend What3words is that it can save them precious time getting to the scene of an accident. There are obvious benefits for veterinary surgeons too, not just when called to remote locations, but also when a client's postcode is ambiguous.
What3words is free of charge and can be downloaded for Android and Apple phones. There is also a What3words website, what3words.com, which provides the same service, but that only works online (whereas the app works offline too).
I've reviewed the app in more detail on YouTube here:
According to the survey, 64% of veterinary surgeons now see Brexit as more of a threat than an opportunity for the UK veterinary profession, compared to just half in autumn 2016. Conversely, the number that see Brexit as being more of an opportunity has dropped from 18% to 14% over the same period.
Vets working in academia and industry were the most gloomy: 69% of vets in academia and 58% of vets in industry see Brexit as more of a threat to their own area of work than an opportunity.
The biggest impact appears to have been on veterinary recruitment, with 53% saying Brexit has made it harder to recruit veterinary surgeons, compared to only 18% in 2016. By comparison, only 11% said it has become harder to recruit veterinary nurses.
51% also now consider Brexit as a threat to animal welfare, compared to 43% in 2016.
BVA President Simon Doherty (pictured right, looking decidedly chipper despite it all) said: "As the UK Government ramps up its planning for a no-deal scenario, it’s clear that the veterinary profession is becoming increasingly concerned about the potential impact of Brexit.
"Top of vets’ list of concerns is significant veterinary workforce shortages across critical areas of animal welfare and public health. Veterinary concerns around animal welfare have also increased as the Government continues to stall on introducing new legislation to enshrine animal sentience in UK law before March.
"From pet passports and food safety, to disease surveillance and trade certification, there is no area of veterinary work that is not touched by Brexit. So, we can fully understand why our members are worried about the future. BVA will continue to raise these important veterinary issues with policymakers to ensure the profession is considered as Brexit discussions continue."
The BVA briefings on “Brexit and the veterinary profession” and “No deal Brexit and the veterinary profession” set out all of the issues of interest in more detail.
The study was the first to use prospectively collected data to estimate the prevalence of and risk factors for gingivitis in a cohort of domestic cats, using data from 860 cats aged up to six years enrolled in the Bristol Cats Study. Gingivitis was found to be a common condition in cats aged up to six years, with prevalence increasing with age, from 24.5% in cats less than 12 months old, up to 56.3% in cats between five and six years old. Odds of gingivitis in cats aged three to four years were higher in cats fed a wet only or mixed wet/dry diet compared to those on a dry only diet; cats not reported to hunt prey compared to reported hunters; cats reported to dribble whilst being stroked at age six months compared to reported non-dribblers; and cats with orange variants in their coat colour compared to non-orange cats. Sex was not found to be a risk factor for gingivitis (Ed's note: what a relief). Jess Williams, lead author of the study, said: “Periodontal disease is one of the most common conditions in cats, potentially causing issues with eating and behaviours like grooming.
"Our study showed that even young cats may have signs of gingivitis, so it is important to discuss and monitor dental health regularly and early on in a cat’s life, especially for those cats who may be more at risk.”
The study was funded by BSAVA PetSavers.
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13737
Equitop GLME is a palatable, pearl formulation joint supplement developed to support the healthy function of cartilage, joint capsules, tendons and ligaments. It is derived from an active extract of New Zealand Green Lip Mussels - a natural source of glucosaminoglycans (GAGs), chondroitin and essential fatty acids – and is tested free of prohibited substances.
Boehringer says the nutrients in Equitop GLME help to lubricate joints, as well as supporting normal joint function, the stability and elasticity of ligaments and the shock-absorbing properties of cartilage.
Equitop GLME is fed once a day either separately or mixed with feed and one tub will typically last for 30 days and can be used in all horses and ponies.
Dr Amy Scott, brand manager for Equitop GLME at Boehringer Ingelheim, said: "By encompassing Equitop GLME into the Equitop portfolio and launching easy-to-read new packaging, we are enhancing our product offering to both veterinary practices and horse owners."
For more information, contact your Boehringer account manager.
In a separate statement, Mr Stevens said: "Anything that gives homeopathy a veneer of credibility risks chancers being able to con more people into parting with their hard-earned cash in return for bogus treatments which at best do nothing, and at worst can be potentially dangerous."
One of the dangers Mr Stevens referred to was the "rise in misinformation about vaccines - some of which is apparently promoted by homeopaths - and which poses a significant danger to human health."
In other words, anyone gullible enough to believe that a dilution of 1,000,000,000,000 parts of water to one part of crude oil, or skimmed milk, or human placenta, or condoms, or anything else for that matter, is going to cure them of anything, is more likely to believe all sorts of anti-vaccine, anti-pharmaceutical company nonsense, something which is very dangerous at a time when vaccination rates have been declining.
Human medicine does not have the monopoly on nonsense, of course. There are those who continue to peddle the lie that homeopathy can cure cancer in animals, and as the declining rates of human vaccination would tend to suggest, no shortage of people prepared to believe them.
Niall Taylor MRCVS, author of No Way To Treat a Friend, said: "The situation in the veterinary profession mirrors that in the medical profession: a small number of people preaching the benefits of a discredited belief system to vulnerable people.
"Some in the profession argue that we should humour those owners who practise homeopathy in animals, as to challenge them would drive them underground. The problem is that if we don't challenge them, we help foster a belief system which doesn't just harm animal health, but human health too. So the skill here is to find ways to challenge these beliefs in a way that is empathetic and constructive."
Protexin says Pro-Kolin Advanced contains beneficial micro-organisms, several prebiotic sources, an optimal level of a dual-source binding agent and soothing fibres to support gastrointestinal function.
The company also says that in a study involving 148 dogs, Pro-Kolin Advanced significantly improved clinical outcome compared to a placebo1.
Protexin Veterinary Director, James Kyffin, said: "Pro-Kolin Advanced represents an exciting development for Protexin Veterinary and fits in perfectly with our ethos to produce innovative, research-based products of the highest quality for pets.
"It is the first product of its kind to be supported by a randomised, controlled clinical trial that was undertaken in first opinion veterinary practices across the UK and Ireland.
"Not only are we pleased to be able to offer veterinary surgeons with an evidence-based option for the management of acute gastrointestinal disturbances, but also a very palatable formulation that was readily accepted by 92% of the dogs in the study."
Pro-Kolin Advanced is available in 15ml, 30ml and 60ml syringes for dogs and 15ml syringes for cats. The flavourings used in the product contain no proteins or common allergens so Pro-Kolin Advanced can be used in animals with known hypersensitivities.
Reference
Christine will take over from Nigel Gibbens who is stepping down at the end of February 2018 after 10 years in the post.
Christine, who comes from a farming family in the south of Scotland, is an experienced veterinary surgeon who worked for a number of years in private practice in Scotland and the north of England, prior to joining the Animal Health agency (now part of the Animal and Plant Health Agency) in 2008 as a Divisional Veterinary Manager in Scotland.
Since 2016, she has been working as the CVO in New South Wales, Australia, where she has led major improvements to biosecurity across many farming sectors.
Christine said: "I am delighted to have been appointed and it will be a privilege to lead my veterinary colleagues to support our farming and food industry in this hugely important role.
"I am very much looking forward to working again with the team at Defra, its agencies, the devolved administrations and all the individuals and groups which will contribute to meet future challenges across animal health and welfare.
"The UK Government has made no secret it wants to cement its place as a world-leader on animal welfare as they leave the European Union, and I’m delighted to have an opportunity to play a part in that."
Nigel said: "I would like to congratulate Christine on her success against a strong field of candidates and I am certain she will be a great addition to the department.
"Her breadth of experience from work within Government and in the private sector will enable her to provide excellent veterinary leadership to the Defra group to deliver government’s ongoing commitment to maintaining our high animal health and welfare standards and to represent the interests of the whole of the UK internationally."
Animal Welfare Minister Lord Gardiner added: "I warmly welcome Christine to her important role. She brings to it a wealth of experience and enthusiasm.
"This Government is embarking on an ambitious programme of animal welfare reform, including plans to increase the maximum sentence for animal cruelty to five years in prison and introducing mandatory CCTV in all abattoirs. Christine will be invaluable in helping us in achieving world leading standards.
"I thank Nigel Gibbens for his outstanding contribution as CVO over the past ten years. Leaving the department at the end of February, he is hugely respected across the veterinary community and beyond – leading on responses to disease outbreaks including avian influenza and advising government on issues from antimicrobial resistance to animal welfare."
British Veterinary Association President John Fishwick said: "We’d like to congratulate Christine Middlemiss on her appointment as the UK’s next CVO and welcome her return to Defra - as well as to the UK, following her 16 months as CVO in New South Wales, Australia.
"As Christine notes, she will take up her role amidst EU Exit negotiations when the vital role veterinary surgeons play in so many areas of political and public life must be championed and considered more than ever.
"The work of all vets in government is indispensable in protecting and promoting animal health and welfare and public health, and current UK CVO Nigel Gibbens CBE has been crucial in steering this with calm direction and sage insight from the heart of government.
"We hope to continue our effective working relationship with the new UK CVO, and really look forward the opportunity to work with Christine moving forwards."
Christine will take up her new role as CVO for the UK on the 1 March 2018.
The new vaccine offers up to 12 months' immunity against three of the biggest diseases that cause reproductive failures in pigs.
Alexandre Carvalho, business unit manager for pigs at MSD Animal Health, says the vaccine has the broadest protection against Leptospira on the market, offering protection against nine different serogroups including, Australis and Pomona.
He added: "This vaccine also includes protection against the Tarassov serogroup, which is unique to the product.
"It’s important to note that PORCILIS Ery+Parvo+Lepto can be used for mass vaccination and during pregnancy, which hasn’t been possible with previous products."
There are only 11 other practices in the UK that hold the Gold Standard Award for rabbit care. To achieve it, Valley Veterinary Hospital had to demonstrate excellence across all aspects of rabbit care, including pain relief and management, dentistry and airway management.
The practice was commended on its top-quality facilities, including a dedicated exotic department with separate waiting and consulting rooms, as well as kennel areas for rabbits to keep them away from larger animals, relieving them of stress and anxiety.
Valley Veterinary Hospital exotic animals specialist, Tariq Abou-Zahr, BVSc CertAVP(ZooMed) MRCVS (pictured right), said: "I am absolutely delighted that Valley Veterinary Hospital has met the grade to achieve the first RWAF gold status in Wales. I believe that rabbits are just as deserving of excellent veterinary care as cats and dogs, and I am so pleased that I work in a veterinary hospital where we have the facilities to provide this standard of care.
"Rabbit medicine has always been an interest of mine, and I’m very grateful to Vet Partners for investing in such great facilities and to RWAF for considering our application and granting us Gold status."
Applications for the Awards are assessed by Dr Richard Saunders BSc Hons MSB CBiol DZooMed MRCVS, one of the UK’s leading specialists on rabbit welfare and veterinary advisor for RWAF.
Dr Richard Saunders BSc Hons MSB CBiol DZooMed MRCVS, who assesses applications on behalf of the RWAF, said:
"As a dedicated rabbit charity aiming to improve the wellbeing and welfare of domestic rabbits throughout the UK, our requirements to meet a Gold standard in rabbit care are very high. Valley Vets has met all of these standards and I’m delighted to reward a practice in Wales who have demonstrated that they are as passionate about rabbit care as we are.”
The RWAF has published a list of award-winning rabbit-savvy practices on its website which can be viewed here: https://rabbitwelfare.co.uk/rabbit-care-advice/rabbit-friendly-vets/rabbit-friendly-vet-list/
Any veterinary practices interested in applying for the Rabbit Friendly Vet List should visit https://rabbitwelfare.co.uk/rabbit-vets/vet-membership/
RSA has confirmed the initial 27 practices that have joined its new Preferred Referral Network, launching today.
The creation of the network means that whilst veterinary surgeons can continue to appoint referral practices as they do now, owners of animals needing a non-emergency referral outside the RSA network may need to pay £200 towards the cost of treatment.
The new rules currently apply to holders of policies issued by Tesco Bank and MORE TH>N, however RSA says it is in discussion with other insurance brands about adopting the new network.
RSA says the Preferred Referral Network will enable it to provide competitively priced products and deliver a range of benefits for customers including:
The company is highlighting the fact that its new network fields 178 RCVS, EBVS or AVMA recognised specialists, 49 Diploma holders and 71 Certificate holders or Advanced Practitioners, working at a mixture of large, multi-disciplinary centres (including five with links to university teaching hospitals), independents and corporates.
RSA says that over the last 12 months, vets have directed more than half of all RSA cases to the 27 practices in its network.
Bill Paton, Claims Director for UK and Western Europe said: “We are delighted to have twenty seven practices from around the UK join our preferred referral network. This is a huge step forward and will enable us to continue to provide competitively priced insurance cover with access to the highest standards of veterinary treatment and care.
"We expect further practices to join the Network in due course and we are actively engaged in discussions with a number of referral practices of varying size and scale, which have expressed an interest in joining."
The 27 referral practices are:
South East
South West
Midlands
North West
North East
East
Scotland
* referral arrangements still being finalised
Concern has been expressed in the profession about environmental contamination from products used in companion animal treatment for ectoparasites, such as fleas and ticks.
In recent years there has been a widely documented fall in the abundance of many terrestrial invertebrate populations1.
While the decline has been mostly linked to agricultural chemicals, there is a concern that companion animal ectoparasiticides could also be a contributing factor, with a recent study2 confirming the presence of common compounds used in flea-treatment3 in UK waterways.
However, the association with companion animal ectoparasiticides is currently poorly understood, with a significant knowledge gap and little robust research available to assess the true importance and environmental consequences.
The funded project ‘Assessing the Environmental Risk from Ectoparasite Treatments in Companion Animals’ will be led by Professor Richard Wall, Professor of Zoology and Dr Emily Bell, Senior Lecturer at University of Bristol in collaboration with Dr Imogen Schofield, Veterinary Statistician and Epidemiologist at CVS, and Lizzie McLennan-Green, Small Animal Veterinary Director at CVS.
It will be conducted via a PhD studentship at the University of Bristol as part of the CVS Clinical Research Awards.
The research will include a longitudinal ‘citizen science’ study with pet owners to develop a greater understanding of owner use and attitudes towards ectoparasiticides.
It will also include laboratory assessments of ectoparasiticide residues collected from companion animals to provide evidence-based information on the potential environmental impact of the treatments when applied to companion animals.
It is hoped the study will help the wider veterinary profession develop the most appropriate approaches to prescribing and use of ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’. The study is also set to benefit companion animals, as the research will inform strategies to ensure the most appropriate control of parasitic burden to pets.
The project starts in January 2023 and will run for three-years as a full time PhD.
CVS is providing £95,000 to fund the research.
References
The RCVS is to launch a consultation in the New Year on proposals to allow all RCVS-registered veterinary surgeons to use the courtesy title 'Dr'/'Doctor', and is seeking the views of all members of the veterinary and veterinary nursing professions, and the general public.
The proposals were raised by RCVS President Stuart Reid at RCVS Day in July 2014, with the aims of aligning the UK with international practice, providing greater clarity for the profession and offering reassurance to clients and the animal-owning public that all veterinary surgeons registered with the RCVS, regardless of where they qualified, have veterinary degrees of an appropriate standard.
In his speech in July, Stuart highlighted that most international veterinary surgeons use the title and that, in Australia and New Zealand, this is frequently tied to registration and professional standing, rather than necessarily academic attainment. He went on to outline that, of the three main clinical degrees in the UK, ie medicine, dentistry and veterinary medicine, only veterinary surgeons do not use the courtesy title 'Doctor'.
Stuart added: "given the fact that all continental EU graduates carry the title 'Doctor', there is now a greater chance of confusion for the lay public than previously.
"This is now an opportunity to provide, for those UK veterinary surgeons who wish it, the legitimate use of a title that offers a level of parity with fellow medical professionals."
The key objective of the consultation is to gauge whether the public and the profession are in favour of the proposal, not in favour of it, or don't mind either way. If agreed, the use of the title would be optional, although the College would regulate its use through the RCVS Code of Professional Conduct.
Background information and draft guidance on using the title is available to read on the RCVS website at www.rcvs.org.uk/doctortitle, from where respondents can follow a link to answer the consultation questions.
The consultation will open officially on Tuesday, 6 January for six weeks (deadline for responses is 5pm on Monday, 16 February) although it is already available to view via the RCVS website, to allow more time for responses over the Christmas and New Year break.
Do you think vets should be called 'Dr'? Discuss here.
Petplan has launched this year's Insurance Advisor Award in association with VetSurgeon.org, and is calling for nominations.
The award is to recognise the hard work and dedication that Petplan Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.
Petplan says pet owners often look to vet staff to help them better understand veterinary procedures, treatment and medication, but they're also increasingly looking for advice about insurance, and that is why it is important that a formally trained member of staff is available to answer customer queries when it comes to pet insurance.
Petplan works with over 4,000 veterinary practices throughout the UK to promote pet insurance. These are Appointed Representative (AR) practices who receive training and certification to speak about specific insurance policies. The PIA scheme is an extension of this - AR practice staff can train to become a dedicated Pet Insurance Advisor by registering on www.petplan.co.uk/pia
Becoming a PIA allows vet staff to earn valuable CPD points whilst developing transferable skills such as confidently promoting products and handling client objections.
Deputy Veterinary Practice Manager Kelli Vogt, of Polsloe Veterinary Clinic in Exeter, who won the 'Petplan Insurance Advisor Award 2010', said: "The scheme is such a great programme and I recommend it to all my colleagues and anyone that will listen. It's a great link between veterinary practices and insurers and it means that we can really help pet owners have financial security should anything happen. The more pet owners are informed of the importance of pet insurance the more likely it'll become mandatory, which will allow them to always get the best possible treatment for their pet without having to worry about the financial implications."
Director of Petplan, Neil Brettell said: "We are incredibly proud to help recognise the hard work and dedication that Petplan Insurance Advisors give their customers, helping to keep them constantly informed and up-to-date. So please get your nominations in!"
To nominate your dedicated colleague for the Petplan Insurance Advisor Award, please visit www.petplan.co.uk/pia. The PIA of the Year will receive a 16GB Ipad2 with WiFi, worth £399.
Nominations close on 9th September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress, taking place from Friday 7th - Sunday 9th October 2011.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.petplanpia.co.uk.
To find out more about Petplan visit http://www.petplan.co.uk/
Time spent discussing the articles can be claimed towards the annual CPD requirement by pressing the ‘Claim CPD’ link at the top of the forum discussion thread.
The first article up for discussion is “What diet should we feed a cat or dog with cancer?”, by Owen Davies, who will be joining us in the forum.
Owen is an RCVS, American and European Specialist in Veterinary Oncology working at Highcroft Referrals.
He graduated from Cambridge in 2005, worked in rural practice for three years, followed by a spell working for charities and then at a large hospital.
In 2014, he moved to the RVC to specialise in oncology before joining Highcroft in 2017.
VetSurgeon.org Clinical Editor, Alasdair Hotston Moore said: “For general practitioners, I think this adds a really valuable extra dimension to your clinical reading.
“It’s not just the opportunity to ask questions of the author, but also to discuss the implications and practicalities of the article amongst yourselves.
VetSurgeon.org Editor, Arlo Guthrie added: “More than that, it’s also in a closed professional community where you can be 100% confident of a friendly atmosphere and authoritative opinions with provenance.
“And more even than that, the questions you ask and the discussion you have are then available as a useful, searchable resource for everyone in the profession.”
So do come and join in.
First read the article here: https://www.veterinary-practice.com/article/what-diet-should-we-feed-a-cat-or-dog-with-cancer
Then come and join the discussion here: https://www.vetsurgeon.org/001/veterinary-clinical/small-animal/f/misc-case-discussions/30507/new-clinical-article-club-what-diet-should-we-feed-a-cat-or-dog-with-cancer-with-owen-davies
As part of the campaign, veterinary practices are being urged to measure their feline patients’ blood pressure from seven years of age and above, as recommended by ISFM (International Society of Feline Medicine) 1.
Ceva says it will also continue the Mercury Challenge, its study of feline blood pressure, throughout 2019 to help increase veterinary professionals' confidence in measuring blood pressure and identifying feline hypertension.
The company says that since June last year, 128 practices and over 1,000 cats have participated in the challenge. You can registered to take part at: mercurychallenge.ceva.com, where there's a chance to win diagnostic tools to help diagnose feline hypertension.
Dr Rosanne Jepson, American, European and RCVS Specialist in Small Animal Internal Medicine at the Royal Veterinary College, said: "It is great to see that so many cats (over 1000!) and practices in the UK have been involved with the Mercury Challenge promoting the measurement of blood pressure and detection of hypertension.
"I would urge as many practices as possible to measure blood pressure; it’s simple, quick and easy to perform and means that we can help prevent target organ damage which at its most severe can leave cats sadly blind for the rest of their life. With careful identification and treatment this can so easily be prevented."
To help raise awareness of Feline Hypertension Month, Ceva has produced a range of marketing materials including waiting room displays, a pet owner leaflet and veterinary marketing packs, which are available upon request.
The initiative will be supported with an extensive PR campaign aimed at pet owners, including a radio day starring CBBC’s Rory the Vet.
For more information, contact cevauk@ceva.com or visit mercurychallenge.ceva.com.
Equibactin oral powder comes in a 60g sachet, which Dechra says is the scientifically considered accurate dose1 for two daily treatments for a 600kg horse. The sachets come in a box of 10, which is sufficient for the twice daily treatment of a 600kg horse for five days.
The combination of sulfadiazine and trimethoprim antibiotics (known as TMPS) has a broad spectrum of uses and can be used to treat equine infections associated with Streptococcus and Staphylococcus aureus, gastrointestinal infections associated with E. coli and urogenital infections associated with beta-hemolytic streptococci.
Emma Jennings, Equine and Food Producing Animal Brand Manager, said: “Our product allows for twice daily 30mg/kg treatments, making the treatment of large horses easier and ensuring they receive the correct dose, which is crucial when it comes to tackling antibiotic resistance.”
She added: “TMPS is the only registered oral antibiotic available for use in horses and it is recommended as the first line of treatment for ‘common’ equine bacterial infections including those which have developed through wound infections or open or drained abscesses.2,3
“Effective antibiotics are an important part of the veterinarian’s arsenal when it comes to treating a variety of common bacterial infections in horses. But in recent years, the emergence of drug resistant bacteria has meant that extra precautions must be taken to prevent underdosing - one of the prominent causes of drug resistance.”
Equibactin oral powder is available now in the UK and Ireland. For more information visit www.dechra.co.uk.
Budding veterinary impresario Noel Fitzpatrick has announced the dates for the inaugural VET Festival, an outdoor summer event for the profession which will combine world-class CPD with family entertainment and an evening rock concert headlined by Mike Rutherford of Genesis fame.
The VET Festival, sponsored by NVSL and Natural Instinct, will take place in the grounds of the University of Surrey on Saturday 5th and Sunday 6th September 2015.
In a complete departure from the way CPD is usually delivered, lectures will take place in a 1000-seat main theatre marquee in the middle of the university campus, surrounded by smaller breakout tents, exhibitors, family entertainment and 'street food'.
Noel said: "The simple goal of The VET Festival is to provide education which is both cutting-edge and relevant to the day-to-day clinical work of vets, vet nurses and veterinary professionals in companion animal practice. But we also seek to make education fun - like going to a movie - something you can treasure, enjoy and then readily employ in clinical practice.
"There are four lecture strands: orthopaedics, oncology and soft tissue surgery, neurology, and veterinary nursing. Ten education themes will be delivered by world-class lecturers with significant experience in clinical veterinary practice. We will present this education on an innovative platform combining a fun festival atmosphere with dynamic delivery. We aim to provide real value for money, with tickets priced very affordably for a packed educational program which can also form part of the 35 CPD points needed throughout the year."
In addition to Noel himself, speakers at the event (pictured below), include: Will Eward (Assistant Professor of Orthopaedic Surgery Duke University), Nick Bacon (Head of Surgical Oncology, Fitzpatrick Referrals), Julia Tomlinson (Diplomate, American College of Veterinary Sports Medicine and Rehabilitation Twin Cities Animal Rehabilitation and Sports Medicine Clinic), Duncan Lascelles (Professor of Surgery and Pain Management at North Carolina State University College of Veterinary Medicine), Ian G Holsworth (Director VetSurg Small Animal Hospital, Ventura, California), Nick Jeffrey (Professor, Neurology and Neurosurgery College of Veterinary Medicine, Iowa State University), Laurent Findji (Senior Surgeon Soft Tissue and Oncology, Fitzpatrick Referrals) and Jolle Kirpensteijn (Chief Professional Relation Officer, Hill's Pet Nutrition).
And if that wasn't enough, there'll be an evening concert on the Saturday headlined by Mike and the Mechanics. The ONE LIVE concert is being held to promote "One Life One Medicine": the belief that we all only have one life and that there should be a symbiosis of effort to move animal and human medicine forward together. It's in support of The Humanimal Trust, the UK's first charity to further the principles of One Medicine and with the aim of progressing clinically relevant healthcare initiatives for both animals and humans at the same time.
Mike Rutherford said: "I am a huge supporter of 'One Life - One Medicine' - combining animal and human health is an important way forward and I'm looking forward to playing at the Festival, as are the rest of the Mechanics! It will be a fantastic week end - not to be missed!"
As a media partner for the event, VetSurgeon.org will be offering members a special discount, more details to be announced in due course. Publishing Editor Arlo Guthrie said: "Sounds like it should be a lot of fun, and could be a great opportunity for some of our members to meet up and have a pint or two."
All VetSurgeon members can have a 10% discount on the ticket price, by visiting the following link and entering the code VFVSURGEON10
http://www.eventbrite.co.uk/e/the-vet-festival-2015-tickets-16256763417?aff=VFVSURGEON10
For more information about the VET Festival visit: www.vetfestival.co.uk
The College says the speed and accuracy of scans produced by the new scanner will revolutionise the treatment of animals at the Queen Mother Hospital for Animals (QMHA). It also reduces the need for animals to be anaesthetised before being scanned, with most patients now only requiring partial sedation.
The new scanner has been named the 'Otter Scanner' after a patient of the RVC whose owner was made a significant donation towards the RVC's charity, the Animal Care Trust, which funded the new machine.
Professor Dan Chan, Professor of Emergency and Critical Care Medicine and Medical Director of the QMHA at the RVC, said: "It is very uncommon that such an incredible leap in the care of animals can be achieved with a single innovation.
"Because of the vast improvement in speed and quality of the images produced by the ‘Otter Scanner’ our specialists are now able to obtain much more detailed images of various diseases affecting our patients so that the best possible treatment can be planned.
"At the RVC, one of our most important missions is to always improve the welfare and care of animals and this latest innovation is just another example of that commitment. We are forever grateful to all our supporters who have made this possible."
Tramvetol is presented in two pack sizes of 30 and 100 tablets to assist practices with dispensing and storage as a Schedule 3 controlled drug. The meat flavoured 50mg tablets can also be divided into two equal parts to ensure accurate dosing.
Virbac says Tramvetol is suitable for both short courses and long-term treatment; 2-4mg per kg of Tramvetol can be administered every 8 hours or from 6 hours, if required, based on the intensity of the pain. In addition, Tramvetol has a wide therapeutic window and a maximum daily dose of 16mg per kg.
Commonly used in combination with other forms of analgesia, including NSAIDs1, Tramvetol is quickly absorbed and boats a rapid onset of action2. Peak plasma concentrations are achieved within 45 minutes3.
Dan Johnson, Product Manager at Virbac said: ‘Tramadol is already an important part of the analgesia toolkit for many veterinary practices. We hope that Tramvetol will prove to be a much more convenient option for practices, whilst helping to provide dogs with a better quality, pain free life’.
For more information, contact your Virbac Territory Manager.
The company hired Onswitch to call 700 veterinary practices and ask about kennel cough. 43% of callers were told it was up to them whether their dog had a vaccine for CIRD, with no clear recommendation in over 50% of calls.
MSD says that there was very little detailed information given about CIRD or kennel cough or vaccinations, with nothing at all mentioned in 18% of calls.
Whilst 18% of calls mentioned that dogs can contract kennel cough mixing with other dogs, 9% were told that their dog would only need the vaccination if it was going into kennels!
According to the company, vaccination for Bordetella bronchiseptica and canine parainfluenza virus has declined dramatically during lockdown, with over 350,000 less doses being bought in 2020 vs 2019 April - December1, however the risks are still prevalent, because dogs are still mixing.
Michelle Townley, Veterinary Advisor for the Companion Animal team at MSD Animal Health said: "CIRD, more commonly known as kennel cough, is often mistakenly believed to be only a disease of kennels. The reality is that respiratory pathogens are most commonly transmitted between dogs that mix or share the same air space. This results in risk anywhere where dogs are being social, including parks, groomers and vet practices. Due to this confusion, we recommend referring to the disease with pet owners as contagious canine cough."
She added: "This data reveals a significant amount of confusion in the advice veterinary practices give to dog owners in relation to protection against CIRD,or contagious canine cough. Practice team members have often received no formal training on what to tell dog owners and how to discuss CIRD, so messages vary widely and are not always correct. This data reveals that there is a great opportunity for practices to proactively discuss contagious canine cough as a standard component of the annual vaccination programme and ensure more dogs that socialise with other dogs and are at risk get the protection they need."
For more information on the Nobivac vaccine range, vaccine protocols and product and team training, contact your MSD Account Manager or visit www.nobivacrespirabb.co.uk.
The £35 course is aimed at veterinary surgeons, veterinary nurses, receptionists and practice managers who may be faced with difficult and sensitive conversations around pet loss with clients. It covers:
Empathy vs sympathy
Communicating with active listening skills
Open questions
Face-to-face emotional support, telephone support, email support and other written communication
The Blue Cross says that the new course complements its £280, eight-week 'Pet Bereavement Support' course for more in-depth training, and also its hourly webinars, which cost £20.
The eight-week course requires a minimum of three to four hours of study per week and counts towards 32 hours Continual Professional Development.
For specific needs, the Blue Cross can also work with practices to provide bespoke face-to-face training across the UK, specifically tailored and delivered at the practice.
For more information, visit www.bluecross.org.uk/pbss-course or call 01993 867216.
PawSquad, which was founded in 2015 by Diwaker Singh and Radu Georgescu, offers veterinary consultations by video and live text chat in the United Kingdom. IVC says it continue to operate as an autonomous entity within the IVC group.
PawSquad CEO, Dr Mark Boddy MRCVS (pictured right) said: “Our network of experienced veterinarians has already helped many thousands of pets in the UK, providing medical advice, emergency triage and preventive health plans. Being part of IVC will allow us to help even more pets and to continue to work positively and collaboratively with the veterinary profession, as well as expand geographically.”
Stuart Caton, Chief Commercial Officer at IVC Evidensia said: "Telemedicine will support the efforts of the group to make high quality veterinary care more accessible to pet owners, lowering the barriers to engagement with the veterinary profession. It’s an excellent acquisition that will further complement the group as pet services grow and evolve in the future. We are delighted the entire PawSquad team will continue with the business supporting their corporate and private clients as before.”
IVC says the accessibility of the PawSquad service encourages pet owners to seek professional advice earlier and more frequently, with around half of all queries being referred for necessary in-clinic follow-up and otherwise providing much valued reassurance and peace of mind.
The company also says telemedicine is particularly appreciated by cat owners or those with nervous dogs, where the stress of a clinic visit can sometimes result in those pets missing out on veterinary care.
PawSquad Chairman and Founder, Diwaker Singh said: “We are pet lovers and launched PawSquad with the objective of making sure that pet owners have instant 24/7 access to quality pet care, accessible from their homes. Towards this end, PawSquad is a great success. The service has grown significantly, confirming there is a clear need for this service. IVC Evidensia’s extensive network will help the business strengthen and grow to even greater heights.”
The surgery was carried out in August 2018 and is, they say, the first time it has been performed on a companion animal anywhere in the world. The dog, a five-year old spaniel called Gigha, has now made a full recovery.
Gigha’s surgery was carried out by Dr Guy Killick and featured in a recent episode of The Yorkshire Vet. Guy said: "Gigha provides vital companionship to her owner, Mrs Taylor. She fell into a drainage ditch last summer and this caused a tiny cut on her elbow.
"The initial wound did not seem severe, however, despite intensive decontamination and treatment with broad spectrum antibiotics, the wound proved to have been infected with a resistant Haemolytic E. coli infection, causing a significant loss of skin from the medial aspect of the elbow. During this time, Gigha was hospitalised and was at significant risk of DIC and septicaemia."
"The skin loss was full thickness and, once the compromised tissue was debrided away, she was left with a large wound.
"We managed the wound in hospital for four days with daily dressing changes and an irrigation device to provide local anaesthesia and the delivery of topical antibiotics.
"Unfortunately, skin grafting in her case was not suitable given the infection and a lack of sufficient loose skin to donate. As such, we elected for healing by second intention but, given the large area, we felt it was important to explore novel methods to accelerate the healing process and reduce Gigha’s pain.
"Surgery using Tilapia fish skin grafts was pioneered at UC Davis in the USA and was used successfully on a horse with acid burns in the UK last year. It is still very rare, however, and had not been used to treat an infected wound before. Nor had it been used on a dog.
"Having done our research though and finding that these grafts have a natural anti-infective and analgesic effect, while also reducing the frequency of bandage changes that would cause discomfort and distress to the patient, we felt it was an appropriate treatment for Gigha and carried out the surgery a week after the initial wound."
Guy says the surgery was straightforward and simply involved tacking the skin in place. It adhered to the developing granulation bed, accelerating its growth and providing an antiseptic and analgesic effect. After application, Gigha’s owner reported that she was much brighter and seemed to be in less pain. Pain-scoring during check-ups confirmed this to be the case despite pain relief being voluntarily withdrawn by the owner.
This initial graft stayed in place for two weeks before breaking down and being removed. By this stage, granulation of the wound had been completed and around one cm of neo-epithelisation had occurred. A further graft was then placed which remained for a further two weeks until the wound was 50% of its initial size. No further grafts were placed as the team did not have access to further supplies so they simply bandaged the wound with traditional bandages. It was completely healed within nine weeks. Eight months on, Gigha has made a full recovery and the wound has healed completely.
Guy said: "Given the large wound area and risk of further infection we decided on this novel approach to improve the quality of life for the patient while the wound was healing. While we were naturally apprehensive of making the first attempt at this potentially revolutionary technique, what we knew about fish skin grafts and suggested that they could work in her case so we were determined to give it a try.
"Looking at her now, you wouldn’t believe that she’d been days from death just a few months ago. Her case is a demonstration of the efficacy of fish skin grafts as a treatment for large wounds where there are no other suitable methods of closure – and for their use in dogs. We hope her story and her recovery will be useful to colleagues treating dogs with similar wounds in the future and are happy to discuss the case with them if this would be helpful.
"I would also like to thank Dr Jamie Peyton, Chief of Integrative Medicine Service at UC Davis for her invaluable help and advice during this case and her assistance in the use of the Tilapia graft."